OBJECTIVE: Risk for developing cervical neoplastic disease is greatly increased in women infected with oncogenic sexually transmitted human papillomaviruses (HPVs) and who have lowered cellular immunity due to coinfection with human immunodeficiency virus (HIV) infection. The majority of these individuals are low-income minority women. Factors associated with promotion of HPV to cervical neoplasia in HIV-infected populations include degree of immunosuppression as well as behavioral factors such as tobacco smoking and psychological stress. This study examined the effects of a cognitive behavioral stress management (CBSM) intervention on life stress and cervical neoplasia in HIV+ minority women. METHODS:Participants were 39 HIV+ African-American, Caribbean, and Hispanic women with a recent history of an abnormal Papanicolaou smear. Participants underwent colposcopic examination, psychosocial interview, and peripheral venous blood draw at study entry and 9 months after being randomly assigned to either a 10-week CBSM group intervention (n=21) or a 1-day CBSM workshop (n=18). RESULTS: Women assigned to the 10-week group-based CBSM intervention reported decreased perceived life stress and had significantly lower odds of cervical neoplasia over a 9-month follow-up. CBSM effects on life stress and neoplasia appeared independent of presence of neoplasia at study entry, HPV type, CD4+CD3+ cell count, HIV viral load, and substance use. Furthermore, CBSM intervention effects on cervical neoplasia were especially pronounced among women with residual life stress at follow-up. CONCLUSION: These findings suggest that stress management decreases perceived life stress and may decrease the odds of cervical neoplasia in women with HIV and a history of abnormal Papanicolaou smears. Although preliminary, these findings suggest the utility of stress management as a cancer prevention strategy in this high-risk population.
RCT Entities:
OBJECTIVE: Risk for developing cervical neoplastic disease is greatly increased in women infected with oncogenic sexually transmitted human papillomaviruses (HPVs) and who have lowered cellular immunity due to coinfection with human immunodeficiency virus (HIV) infection. The majority of these individuals are low-income minority women. Factors associated with promotion of HPV to cervical neoplasia in HIV-infected populations include degree of immunosuppression as well as behavioral factors such as tobacco smoking and psychological stress. This study examined the effects of a cognitive behavioral stress management (CBSM) intervention on life stress and cervical neoplasia in HIV+ minority women. METHODS:Participants were 39 HIV+ African-American, Caribbean, and Hispanic women with a recent history of an abnormal Papanicolaou smear. Participants underwent colposcopic examination, psychosocial interview, and peripheral venous blood draw at study entry and 9 months after being randomly assigned to either a 10-week CBSM group intervention (n=21) or a 1-day CBSM workshop (n=18). RESULTS:Women assigned to the 10-week group-based CBSM intervention reported decreased perceived life stress and had significantly lower odds of cervical neoplasia over a 9-month follow-up. CBSM effects on life stress and neoplasia appeared independent of presence of neoplasia at study entry, HPV type, CD4+CD3+ cell count, HIV viral load, and substance use. Furthermore, CBSM intervention effects on cervical neoplasia were especially pronounced among women with residual life stress at follow-up. CONCLUSION: These findings suggest that stress management decreases perceived life stress and may decrease the odds of cervical neoplasia in women with HIV and a history of abnormal Papanicolaou smears. Although preliminary, these findings suggest the utility of stress management as a cancer prevention strategy in this high-risk population.
Authors: J S Bartholomew; S Glenville; S Sarkar; D J Burt; M A Stanley; F Ruiz-Cabello; J Chengang; F Garrido; P L Stern Journal: Cancer Res Date: 1997-03-01 Impact factor: 12.701
Authors: S Cruess; M Antoni; D Cruess; M A Fletcher; G Ironson; M Kumar; S Lutgendorf; A Hayes; N Klimas; N Schneiderman Journal: Psychosom Med Date: 2000 Nov-Dec Impact factor: 4.312
Authors: S W Cole; B D Naliboff; M E Kemeny; M P Griswold; J L Fahey; J A Zack Journal: Proc Natl Acad Sci U S A Date: 2001-10-23 Impact factor: 11.205
Authors: Deidre Byrnes Pereira; Michael H Antoni; Aimee Danielson; Trudi Simon; JoNell Efantis-Potter; Charles S Carver; Ron E F Durán; Gail Ironson; Nancy Klimas; Mary Jo O'Sullivan Journal: Psychosom Med Date: 2003 May-Jun Impact factor: 4.312
Authors: Susan K Lutgendorf; Elizabeth Mullen-Houser; Daniel Russell; Koen Degeest; Geraldine Jacobson; Laura Hart; David Bender; Barrie Anderson; Thomas E Buekers; Michael J Goodheart; Michael H Antoni; Anil K Sood; David M Lubaroff Journal: Brain Behav Immun Date: 2010-06-30 Impact factor: 7.217
Authors: James R Hébert; Kathryn L Braun; Joseph Keawe'aimoku Kaholokula; Cheryl A Armstead; James B Burch; Beti Thompson Journal: Prog Community Health Partnersh Date: 2015
Authors: Roger C McIntosh; Gail Ironson; Michael Antoni; Betty Lai; Mahendra Kumar; Mary Ann Fletcher; Neil Schneiderman Journal: Int J Behav Med Date: 2017-04
Authors: L Stewart Massad; Denis Agniel; Howard Minkoff; D Heather Watts; Gypsyamber D'Souza; Alexandra M Levine; Teresa M Darragh; Mary Young; Anthony Cajigas; Kathleen Weber Journal: J Low Genit Tract Dis Date: 2011-01 Impact factor: 1.925
Authors: Corina R Lopez; Michael H Antoni; Deirdre Pereira; Julia Seay; Nicole Whitehead; Jonelle Potter; Maryjo O'Sullivan; Mary Ann Fletcher Journal: J Appl Biobehav Res Date: 2013-03-08